FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer

The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.

source https://www.nytimes.com/2024/05/16/health/fda-amgen-small-cell-lung-cancer-imdelltra.html